Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains.

× No keyword cloud information.

5 in total

1. Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis.

Authors: A Saleh-Mghir; A Lefort; Y Petegnief; S Dautrey; J M Vallois; D Le Guludec; C Carbon; B Fantin
Journal: Antimicrob Agents Chemother Date: 1999-01 Impact factor: 5.191

2. In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates.

Authors: F García-Garrote; E Cercenado; L Alcalá; E Bouza
Journal: Antimicrob Agents Chemother Date: 1998-09 Impact factor: 5.191

3. Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.

Authors: G W Kaatz; S M Seo; J R Aeschlimann; H H Houlihan; R C Mercier; M J Rybak
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

4. Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection.

Authors: Carole J Boylan; Kristina Campanale; Philip W Iversen; Diane L Phillips; Michael L Zeckel; Thomas R Parr
Journal: Antimicrob Agents Chemother Date: 2003-05 Impact factor: 5.191

5. Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model.

Authors: S A Zelenitsky; B Booker; N Laing; J A Karlowsky; D J Hoban; G G Zhanel
Journal: Antimicrob Agents Chemother Date: 1999-03 Impact factor: 5.191

5 in total